MedTrace Logo

A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma

NCT00190554 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 330

Last updated 2016-09-22

No results posted yet for this study

Summary

To determine whether chemotherapy before surgery makes better outcome than chemotherapy after surgery in patients with esophageal squamous cell carcinoma

Conditions

  • Esophageal Neoplasms
  • Carcinoma, Squamous Cell

Interventions

DRUG

Surgery +(Cisplatin 80 mg/㎡+5FU 800mg/㎡×5days)×2

DRUG

(Cisplatin 80 mg/㎡+5FU 800mg/㎡×5days)×2＋Surgery

Sponsors & Collaborators

  • Ministry of Health, Labour and Welfare, Japan

    collaborator OTHER_GOV

  • Japan Clinical Oncology Group

    lead OTHER

Principal Investigators

  • Nobutoshi Ando, M.D. · Tokyo Dental College Ichikawa General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-05-31
Primary Completion
2004-05-31
Completion
2009-05-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00190554 on ClinicalTrials.gov